Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Activation of human platelets by misfolded proteins.

Herczenik E, Bouma B, Korporaal SJ, Strangi R, Zeng Q, Gros P, Van Eck M, Van Berkel TJ, Gebbink MF, Akkerman JW.

Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1657-65. Epub 2007 May 17.

2.

The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets.

Liu J, Pestina TI, Berndt MC, Steward SA, Jackson CW, Gartner TK.

J Thromb Haemost. 2004 Dec;2(12):2213-22.

3.

A novel role for CD36 in VLDL-enhanced platelet activation.

Englyst NA, Taube JM, Aitman TJ, Baglin TP, Byrne CD.

Diabetes. 2003 May;52(5):1248-55.

4.

Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.

Riondino S, Gazzaniga PP, Pulcinelli FM.

Thromb Haemost. 2001 Feb;85(2):320-5.

PMID:
11246555
5.

Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C.

Praticó D, Pasin M, Barry OP, Ghiselli A, Sabatino G, Iuliano L, FitzGerald GA, Violi F.

Circulation. 1999 Jun 22;99(24):3118-24.

6.

Amyloid beta peptide-activated signal pathways in human platelets.

Shen MY, Hsiao G, Fong TH, Chen HM, Chou DS, Lin CH, Sheu JR, Hsu CY.

Eur J Pharmacol. 2008 Jul 7;588(2-3):259-66. doi: 10.1016/j.ejphar.2008.04.040. Epub 2008 Apr 22.

PMID:
18511035
7.

Effect of antithrombin III on glycoprotein Ib/IX/V activation in human platelets: suppression of thromboxane A2 generation.

Doi T, Tokuda H, Matsushima-Nishiwaki R, Cuong NT, Kageyama Y, Iida Y, Kondo A, Akamatsu S, Otsuka T, Iida H, Kozawa O, Ogura S.

Prostaglandins Leukot Essent Fatty Acids. 2012 Aug-Sep;87(2-3):57-62. doi: 10.1016/j.plefa.2012.05.010. Epub 2012 Jul 21.

PMID:
22819492
8.

Essential role of protein kinase C delta in platelet signaling, alpha IIb beta 3 activation, and thromboxane A2 release.

Yacoub D, Théorêt JF, Villeneuve L, Abou-Saleh H, Mourad W, Allen BG, Merhi Y.

J Biol Chem. 2006 Oct 6;281(40):30024-35. Epub 2006 Aug 8.

9.

Platelet aggregation: involvement of thrombin and fibrin(ogen).

Lisman T, Weeterings C, de Groot PG.

Front Biosci. 2005 Sep 1;10:2504-17. Review.

PMID:
15970513
10.

Comparison of sea turtle thrombocyte aggregation to human platelet aggregation in whole blood.

Soslau G, Prest PJ, Class R, George R, Paladino F, Violetta G.

Comp Biochem Physiol B Biochem Mol Biol. 2005 Nov;142(3):353-60. Epub 2005 Sep 23.

PMID:
16183311
11.

Effect of oxidation on the platelet-activating properties of low-density lipoprotein.

Korporaal SJ, Gorter G, van Rijn HJ, Akkerman JW.

Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):867-72. Epub 2005 Feb 3.

12.

Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation.

Paolini R, Casonato A, Boeri G, Luzzatto G, Girolami A, Sasahara AA, Cella G.

J Med. 1993;24(2-3):113-30.

PMID:
8409776
13.

Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.

Shi T, Giannakopoulos B, Yan X, Yu P, Berndt MC, Andrews RK, Rivera J, Iverson GM, Cockerill KA, Linnik MD, Krilis SA.

Arthritis Rheum. 2006 Aug;54(8):2558-67.

14.

A mechanistic model for paradoxical platelet activation by ligand-mimetic alphaIIb beta3 (GPIIb/IIIa) antagonists.

Bassler N, Loeffler C, Mangin P, Yuan Y, Schwarz M, Hagemeyer CE, Eisenhardt SU, Ahrens I, Bode C, Jackson SP, Peter K.

Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):e9-15. Epub 2006 Dec 14.

15.

Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease?

Kälvegren H, Majeed M, Bengtsson T.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1677-83. Epub 2003 Jul 3.

16.

Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein.

Henry A, Li QX, Galatis D, Hesse L, Multhaup G, Beyreuther K, Masters CL, Cappai R.

Br J Haematol. 1998 Nov;103(2):402-15.

PMID:
9827912
17.

[Functions of thrombin receptors in the reversible distribution of platelet surface glycoprotein I balpha in activated platelets].

Han Y, Pasquet JM, Nurden A, Wang ZY, Ruan CG.

Zhonghua Xue Ye Xue Za Zhi. 2005 Mar;26(3):152-6. Chinese.

PMID:
15946527
18.
19.

Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease.

Mikhailidis DP, Barradas MA, Maris A, Jeremy JY, Dandona P.

J Clin Pathol. 1985 Oct;38(10):1166-71.

20.

Endotoxin-induced activation of equine platelets: evidence for direct activation of p38 MAPK pathways and vasoactive mediator production.

Brooks AC, Menzies-Gow NJ, Wheeler-Jones C, Bailey SR, Cunningham FM, Elliott J.

Inflamm Res. 2007 Apr;56(4):154-61.

PMID:
17522813
Items per page

Supplemental Content

Write to the Help Desk